Stay updated on BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The update is a minor version change (Revision: v3.4.2) and removal of a general government funding status notice; there are no changes to study content, eligibility criteria, primary or secondary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:34:17.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T01:38:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary feature was added; a new 'Last Update Submitted that Met QC Criteria' label and 'Revision: v3.4.0' were introduced. The existing items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:16:16.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:28:19.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added Moscow Oblast to the Locations section and removed the Moscow Oblast Locations. The page revision was updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:58:06.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:59:27.000Z thumbnail image

Stay in the know with updates to BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.